233 related articles for article (PubMed ID: 32949371)
1. Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis.
Yabe M; Morio T; Tabuchi K; Tomizawa D; Hasegawa D; Ishida H; Yoshida N; Koike T; Takahashi Y; Koh K; Okamoto Y; Sano H; Kato K; Kanda Y; Goto H; Takita J; Miyamura T; Noguchi M; Kato K; Hashii Y; Astuta Y; Yabe H
Int J Hematol; 2021 Jan; 113(1):134-144. PubMed ID: 32949371
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group.
Giardino S; de Latour RP; Aljurf M; Eikema DJ; Bosman P; Bertrand Y; Tbakhi A; Holter W; Bornhäuser M; Rössig C; Burkhardt B; Zecca M; Afanasyev B; Michel G; Ganser A; Alseraihy A; Ayas M; Uckan-Cetinkaya D; Bruno B; Patrick K; Bader P; Itälä-Remes M; Rocha V; Jubert C; Diaz MA; Shaw PJ; Junior LGD; Locatelli F; Kröger N; Faraci M; Pierri F; Lanino E; Miano M; Risitano A; Robin M; Dufour C;
Am J Hematol; 2020 Jul; 95(7):809-816. PubMed ID: 32267023
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
Peffault de Latour R; Porcher R; Dalle JH; Aljurf M; Korthof ET; Svahn J; Willemze R; Barrenetxea C; Mialou V; Soulier J; Ayas M; Oneto R; Bacigalupo A; Marsh JC; Peters C; Socie G; Dufour C; ;
Blood; 2013 Dec; 122(26):4279-86. PubMed ID: 24144640
[TBL] [Abstract][Full Text] [Related]
4. Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.
Anur P; Friedman DN; Sklar C; Oeffinger K; Castiel M; Kearney J; Singh B; Prockop SE; Kernan NA; Scaradavou A; Kobos R; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F
Bone Marrow Transplant; 2016 Jul; 51(7):938-44. PubMed ID: 26999465
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.
Ayas M; Saber W; Davies SM; Harris RE; Hale GA; Socie G; LeRademacher J; Thakar M; Deeg HJ; Al-Seraihy A; Battiwalla M; Camitta BM; Olsson R; Bajwa RS; Bonfim CM; Pasquini R; Macmillan ML; George B; Copelan EA; Wirk B; Al Jefri A; Fasth AL; Guinan EC; Horn BN; Lewis VA; Slavin S; Stepensky P; Bierings M; Gale RP
J Clin Oncol; 2013 May; 31(13):1669-76. PubMed ID: 23547077
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation.
Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; Moussa E; Karaoui M; Roberts G; El-Solh H
Bone Marrow Transplant; 2004 Jan; 33(1):15-7. PubMed ID: 14578932
[TBL] [Abstract][Full Text] [Related]
8. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
[TBL] [Abstract][Full Text] [Related]
9. Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Hussein AA; Halkes CM; Socié G; Tichelli A; von dem Borne PA; Schaap MN; Foa R; Ganser A; Dufour C; Bacigalupo A; Locasciulli A; Aljurf M; Peters C; Robin M; van Biezen AA; Volin L; De Witte T; Marsh J; Passweg JR; Kröger N;
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1448-50. PubMed ID: 24910382
[TBL] [Abstract][Full Text] [Related]
10. How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R; Soulier J
Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
[TBL] [Abstract][Full Text] [Related]
11. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
13. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
Spitzer B; Jakubowski AA; Papadopoulos EB; Fuller K; Hilden PD; Young JW; Barker JN; Koehne G; Perales MA; Hsu KC; van den Brink MR; Kernan NA; Prockop SE; Scaradavou A; Castro-Malaspina H; O'Reilly RJ; Boulad F
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2088-2095. PubMed ID: 28711727
[TBL] [Abstract][Full Text] [Related]
14. Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years.
Tuysuz G; Guler E; Ozel D; Kupesiz A
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2017-2023. PubMed ID: 31199982
[TBL] [Abstract][Full Text] [Related]
15. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
Satty AM; Klein E; Mauguen A; Kunvarjee B; Boelens JJ; Cancio M; Curran KJ; Kernan NA; Prockop SE; Scaradavou A; Spitzer B; Tamari R; Ruggiero J; Torok-Castanza J; Mehta PA; O'Reilly RJ; Boulad F
Bone Marrow Transplant; 2024 Jan; 59(1):23-33. PubMed ID: 37773270
[TBL] [Abstract][Full Text] [Related]
16. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
[TBL] [Abstract][Full Text] [Related]
17. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
18. [Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia].
Zhao XL; Jiang EL; Zhai WH; Ma QL; Pang AM; Wei JL; He Y; Yang DL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):467-471. PubMed ID: 31340618
[No Abstract] [Full Text] [Related]
19. Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Behfar M; Koochakzadeh L; Yazdanian N; Salajegheh P; Rostami T; Khodayari-Namini N; Ghavamzadeh A; Hamidieh AA
Turk J Pediatr; 2019; 61(3):407-412. PubMed ID: 31916719
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]